<code id='3E674CF7F3'></code><style id='3E674CF7F3'></style>
    • <acronym id='3E674CF7F3'></acronym>
      <center id='3E674CF7F3'><center id='3E674CF7F3'><tfoot id='3E674CF7F3'></tfoot></center><abbr id='3E674CF7F3'><dir id='3E674CF7F3'><tfoot id='3E674CF7F3'></tfoot><noframes id='3E674CF7F3'>

    • <optgroup id='3E674CF7F3'><strike id='3E674CF7F3'><sup id='3E674CF7F3'></sup></strike><code id='3E674CF7F3'></code></optgroup>
        1. <b id='3E674CF7F3'><label id='3E674CF7F3'><select id='3E674CF7F3'><dt id='3E674CF7F3'><span id='3E674CF7F3'></span></dt></select></label></b><u id='3E674CF7F3'></u>
          <i id='3E674CF7F3'><strike id='3E674CF7F3'><tt id='3E674CF7F3'><pre id='3E674CF7F3'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:3
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Hospitals use virtual reality to design more inclusive rooms for kids
          Hospitals use virtual reality to design more inclusive rooms for kids

          ResearcherHaripriyaSathyanarayananobservingasapediatricparticipantexploresahospitalroominvirtualreal

          read more
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more

          Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

          9:45AttorneyforformerPresidentDonaldTrump,JohnLauro,speakstoABC'sGeorgeStephanopoulosonAug.6,2023,in